Sana Biotechnology Inc is a biotechnology company focused on developing and delivering transformative therapies that harness the power of engineered cells to treat a range of diseases
By utilizing innovative approaches in cell engineering and gene therapy, Sana aims to create cutting-edge treatments for conditions such as cancer, genetic disorders, and other serious diseases. The company is dedicated to advancing its scientific capabilities and has a pipeline of product candidates that seek to address unmet medical needs, striving to improve patient outcomes through next-generation cell-based therapies.
Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.
U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSEASPN) fell sharply during Thursday’s session after the company issued a business update.
